Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria

被引：56

作者：

Chiodini, PL

Conlon, CP

Hutchinson, DBA

Farquhar, JA

Hall, AP

Peto, TEA

Birley, H

Warrell, DA

机构：

[1] JOHN RADCLIFFE HOSP,NUFFIELD DEPT MED,OXFORD OX3 9DU,ENGLAND

[2] WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1995年 / 36卷 / 06期

关键词：

D O I：

10.1093/jac/36.6.1073

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The activity of atovaquone in patients with oligosymptomatic Plasmodium falciparum malaria was assessed in an open, non-comparative clinical study. The patients showed a good clinical response, but there was a high rate of recrudescence. The activity of atovaquone in combination with another antimalarial agent should be investigated.

引用

页码：1073 / 1078

页数：6

共 3 条

[1] INHIBITION OF PYRIMIDINE BIOSYNTHESIS DENOVO IN PLASMODIUM-FALCIPARUM BY 2-(4-TERT-BUTYLCYCLOHEXYL)-3-HYDROXY-1,4-NAPHTHOQUINONE INVITRO [J].

HAMMOND, DJ ;

BURCHELL, JR ;

PUDNEY, M .

MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1985, 14 (01) :97-109

[2]

HUDSON AT, 1991, DRUG EXP CLIN RES, V17, P427

[3] COMPARISON OF ATOVAQUONE (566C80) WITH TRIMETHOPRIM-SULFAMETHOXAZOLE TO TREAT PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS [J].

HUGHES, W ;

LEOUNG, G ;

KRAMER, F ;

BOZZETTE, SA ;

SAFRIN, S ;

FRAME, P ;

CLUMECK, N ;

MASUR, H ;

LANCASTER, D ;

CHAN, C ;

LAVELLE, J ;

ROSENSTOCK, J ;

FALLOON, J ;

FEINBERG, J ;

LAFON, S ;

ROGERS, M ;

SATTLER, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (21) :1521-1527

← 1 →